Disc Medicine (IRON) News Today $64.50 +1.55 (+2.46%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by State Street CorpState Street Corp grew its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 39.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 827,910 shares of the company's stock after acquiring an additional 235,115 shares during the quarter. StaDecember 21 at 3:25 AM | marketbeat.comDisc Medicine (NASDAQ:IRON) Stock Price Down 3% - Should You Sell?Disc Medicine (NASDAQ:IRON) Trading Down 3% - Time to Sell?December 20 at 1:04 PM | marketbeat.comJohn D. Quisel Sells 12,791 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockDecember 19 at 8:03 AM | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) CEO Sells $844,333.91 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CEO John D. Quisel sold 12,791 shares of the company's stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $66.01, for a total value of $844,333.91. Following the sale, the chief executive officer now owns 72,065 shares of the company's stock, valued at $4,757,010.65. This trade represents a 15.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.December 18 at 10:23 PM | marketbeat.comY Intercept Hong Kong Ltd Takes $445,000 Position in Disc Medicine, Inc. (NASDAQ:IRON)Y Intercept Hong Kong Ltd acquired a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 9,057 shares of the company's stock, valued at approximately $445,000. A number of other large investors hDecember 17, 2024 | marketbeat.comAnalysts Set Disc Medicine, Inc. (NASDAQ:IRON) Price Target at $85.80December 13, 2024 | americanbankingnews.comDisc Medicine (NASDAQ:IRON) Stock Price Up 5.6% Following Analyst UpgradeDecember 12, 2024 | americanbankingnews.comPromising Pipeline Developments Bolster Buy Rating for Disc MedicineDecember 11, 2024 | markets.businessinsider.comWellington Management Group LLP Has $90.43 Million Stake in Disc Medicine, Inc. (NASDAQ:IRON)Wellington Management Group LLP lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,840,226 shares of the company's stoDecember 11, 2024 | marketbeat.comVerition Fund Management LLC Invests $589,000 in Disc Medicine, Inc. (NASDAQ:IRON)Verition Fund Management LLC acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,980 shares of thDecember 11, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. boosted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 13.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 160,554 shares of the coDecember 11, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Disc Medicine (NASDAQ:IRON)December 11, 2024 | americanbankingnews.comDisc Medicine (NASDAQ:IRON) Earns Outperform Rating from WedbushDecember 11, 2024 | americanbankingnews.comDisc Medicine price target raised to $90 from $79 at StifelDecember 11, 2024 | markets.businessinsider.comDisc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Buy" from AnalystsDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has been assigned an average rating of "Buy" from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation onDecember 10, 2024 | marketbeat.comScotiabank Remains a Buy on Disc Medicine (IRON)December 10, 2024 | markets.businessinsider.comPromising Prospects for Disc Medicine’s DISC-0974: Strong Efficacy in Myelofibrosis-Related Anemia Warrants Buy RatingDecember 10, 2024 | markets.businessinsider.comDisc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual MeetingDecember 9, 2024 | globenewswire.comDisc Medicine (NASDAQ:IRON) Receives "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $118.00 price objective on shares of Disc Medicine in a research note on Monday.December 9, 2024 | marketbeat.comDisc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual MeetingDecember 8, 2024 | globenewswire.comJanus Henderson Group PLC Purchases 303,954 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Janus Henderson Group PLC lifted its position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 68.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 749,827 shares of the company's stock after purchasing an additional 303,954 shaDecember 7, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director William Richard White Sells 1,957 SharesDecember 5, 2024 | insidertrades.comHighVista Strategies LLC Invests $470,000 in Disc Medicine, Inc. (NASDAQ:IRON)HighVista Strategies LLC bought a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 9,565 shares of the company's stock, valued at approximately $470,000. Several other institutional investors anDecember 4, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Walleye Capital LLCWalleye Capital LLC grew its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 53.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 209,236 shares of the company's stock after acquiring an additional 73,14November 30, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Position Cut by Ally Bridge Group NY LLCAlly Bridge Group NY LLC lowered its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 39.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 100,000 shares of the company's stock after selling 66,500 shares during the period. Disc MediNovember 28, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Insider William Jacob Savage Sells 14,183 SharesNovember 27, 2024 | insidertrades.comEagle Asset Management Inc. Sells 15,460 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Eagle Asset Management Inc. reduced its position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 15.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 83,215 shares of the company's stock after selling 15,460 shares during the period. Eagle AssetNovember 25, 2024 | marketbeat.comVictory Capital Management Inc. Has $10.81 Million Stock Position in Disc Medicine, Inc. (NASDAQ:IRON)Victory Capital Management Inc. lowered its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 29.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 220,014 shares of the company's stoNovember 21, 2024 | marketbeat.comWilliam Jacob Savage Sells 9,158 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockNovember 20, 2024 | insidertrades.comCantor Fitzgerald Predicts Disc Medicine FY2024 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2024 earnings per share (EPS) estimates for shares of Disc Medicine in a research report issued to clients and investors on Wednesday, November 13th. Cantor Fitzgerald analyst K. Kluska nowNovember 18, 2024 | marketbeat.comDisc Medicine Announces New Equity Sales AgreementNovember 16, 2024 | markets.businessinsider.comWedbush Estimates Disc Medicine's Q4 Earnings (NASDAQ:IRON)Disc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Wedbush dropped their Q4 2024 earnings estimates for shares of Disc Medicine in a note issued to investors on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per shareNovember 15, 2024 | marketbeat.comDisc Medicine’s Promising Pipeline and Strategic Developments Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comDisc Medicine FY2024 EPS Forecast Raised by HC WainwrightDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Stock analysts at HC Wainwright upped their FY2024 EPS estimates for Disc Medicine in a research note issued on Wednesday, November 13th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings of ($3.88) per share for theNovember 15, 2024 | marketbeat.comDisc Medicine FY2024 EPS Estimate Boosted by Leerink PartnrsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of Disc Medicine in a note issued to investors on Tuesday, November 12th. Leerink Partnrs analyst T. Smith now expects that the company will pNovember 15, 2024 | marketbeat.comFY2024 EPS Estimate for Disc Medicine Increased by AnalystDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at Lifesci Capital raised their FY2024 earnings per share (EPS) estimates for shares of Disc Medicine in a report released on Tuesday, November 12th. Lifesci Capital analyst R. Katkhuda now anticipates that the company will post earningsNovember 15, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have received a consensus recommendation of "Buy" from the ten ratings firms that are covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and one has issued a strong buy recoNovember 15, 2024 | marketbeat.comWedbush Has Optimistic View of Disc Medicine FY2028 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Wedbush upped their FY2028 earnings estimates for Disc Medicine in a research report issued to clients and investors on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of $7.04 per share forNovember 14, 2024 | marketbeat.comDisc Medicine (IRON) Receives a Buy from Stifel NicolausNovember 14, 2024 | markets.businessinsider.comDisc Medicine (IRON) Gets a Buy from Morgan StanleyNovember 14, 2024 | markets.businessinsider.comDisc Medicine (NASDAQ:IRON) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPSDisc Medicine (NASDAQ:IRON - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($1.04) by $0.15.November 13, 2024 | marketbeat.comDisc Medicine to Participate in Upcoming Investor ConferencesNovember 13, 2024 | globenewswire.comDisc Medicine Inc Ordinary SharesNovember 12, 2024 | morningstar.comDisc Medicine’s Strong Financial Position and Promising Clinical Developments Drive Buy RatingNovember 12, 2024 | markets.businessinsider.comDisc Medicine Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 | markets.businessinsider.comDisc Medicine Secures $200M Financing for Hematology PipelineNovember 9, 2024 | markets.businessinsider.comDisc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.November 8, 2024 | globenewswire.comLeerink Partnrs Expects Weaker Earnings for Disc MedicineDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for Disc Medicine in a research note issued on Monday, November 4th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings of ($6.2November 7, 2024 | marketbeat.comDisc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual MeetingNovember 6, 2024 | finance.yahoo.comDisc Medicine price target raised to $70 from $62 at ScotiabankNovember 6, 2024 | markets.businessinsider.com Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼0.570.61▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼65▲IRON Articles Average Week Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Revolution Medicines News Lantheus News Nuvalent News Legend Biotech News Blueprint Medicines News Elanco Animal Health News Cytokinetics News TG Therapeutics News Viking Therapeutics News BridgeBio Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
